Vyripharm is committed to
Helping People Live Better Lives
Quality Assurance and Quality Control is Vyripharm's focus for enhancing public safety, public health and public awareness.
About UsQuality Assurance and Quality Control is Vyripharm's focus for enhancing public safety, public health and public awareness.
About UsWith the ongoing COVID-19 pandemic, the pharmaceutical and medical industry is working around the clock to develop treatments, vaccines and accurate in-vitro testing applications of the viral infection.
Comprehensive Regulatory Traditional and Non-traditional Drug Testing
Maintaining GLP/GMP regulatory standards for synthetic pharmaceuticals and natural pharmaceuticals (botanicals)
Theranostic products for Personalized Medicine
"Personalized Medicine"- providing patients with the right drug, at the right dose, at the right time
Vyripharm® is a leading biopharmaceutical/biotechnology innovator in personalized medicine. Vyripharm’s mission is the integration of traditional and alternative medicine. Vyripharm’s focus is to integrate medical platforms in diagnostic & therapeutic applications in disease areas of infectious diseases, neurological disorders, and cancers.
Vyripharm® is also uniquely positioned to become the standard and exclusive sole source of government-approved licensing for tracking, tracing, certifying, compliance monitoring, and testing for Medical Botanical products slated for human consumption or medical treatments to maintain and improve public health and safety.
Vyripharm® also integrates bio-medical informatics and block-chain technology into a global data collection system for better understanding of diagnosis, therapeutic and treatment outcomes, with the integration of R&D to address different disease states and public safety requirements.
The company has patents in sectors such as Regulatory Testing, Pharmaceutical and Diagnostic Drugs, Bioinformatics, Medical Informatics, Monitoring Technology, and Drug Delivery Systems. The company holds exclusive licenses, issued patents, patents pending and trademarks.
Pharmaceuticals and Radiopharmaceuticals. Vyripharm develops novel platforms for molecular imaging and therapy.
Contact Us